Detalles de la búsqueda
1.
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody.
Oncologist
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38478404
2.
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
BMC Cancer
; 23(1): 547, 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37322411
3.
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
BMC Cancer
; 23(1): 1017, 2023 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37867191
4.
Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma.
Hepatol Res
; 52(8): 721-729, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536197
5.
CFHBA-PID Algorithm: Dual-Loop PID Balancing Robot Attitude Control Algorithm Based on Complementary Factor and Honey Badger Algorithm.
Sensors (Basel)
; 22(12)2022 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746273
6.
Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis.
HPB (Oxford)
; 24(4): 547-557, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34635434
7.
Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study.
HPB (Oxford)
; 24(10): 1703-1710, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35523655
8.
Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China.
HPB (Oxford)
; 24(7): 1063-1073, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34961677
9.
A stable and reliable animal model for hepatocellular carcinoma with portal vein tumor thrombus.
Hepatobiliary Pancreat Dis Int
; 21(1): 90-93, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810986
10.
Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis.
Mol Biotechnol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38683442
11.
Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma.
Hepat Med
; 15: 249-264, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38162389
12.
A new and rare type of hepatocellular carcinoma: Survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma.
Pathol Res Pract
; 241: 154260, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36509007
13.
Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.
Eur J Surg Oncol
; 49(7): 1226-1233, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739252
14.
Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study.
Front Oncol
; 13: 1101038, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37197414
15.
Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence.
Technol Cancer Res Treat
; 22: 15330338231212726, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37933176
16.
Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism.
Front Nutr
; 10: 1076569, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866057
17.
A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study.
Cancer Med
; 12(9): 10294-10302, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880150
18.
Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.
Cancer Med
; 12(10): 11513-11524, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999793
19.
Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial.
Heliyon
; 9(9): e20015, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37810112
20.
Serum metabolomics analysis of biomarkers and metabolic pathways in patients with colorectal cancer associated with spleen-deficiency and qi-stagnation syndrome or damp-heat syndrome: a prospective cohort study.
Front Oncol
; 13: 1190706, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37771438